FDA Inspection 1015118 — Boston Medical Center and Boston University Medical Campus IRB

Boston Medical Center and Boston University Medical Campus IRB — FEI 1283359

The FDA completed an inspection of Boston Medical Center and Boston University Medical Campus IRB on June 8, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

IRB